Life Sciences

Vanda Challenges FDA Over Limits on Off-Label Drug Comm...

Vanda Pharmaceuticals is pushing back against the U.S. Food and Drug Administrat...

Pfizer Decides Against Pursuing Lead Obesity Asset Amid...

Pfizer said that it had discovered a possible instance of medication-induced liv...

Rallybio Drops Maternal Disorder Drug Following Phase 2...

US-based biotechnology company Rallybio is discontinuing its RLYB212 program for...

Trump’s Proposed Pharmaceutical Tariffs May Potentially...

The U.S. may soon impose significant tariffs on pharmaceutical imports, accordin...

Eli Lilly provides a $1.4 billion gene therapy contract...

Through its licensing deal with Eli Lilly, Sangamo Therapeutics received $18 mil...

OPM Cuts Staff, Executive Wages in Wake of Servier Exit

The French biotech company Oncodesign Precision Medicine has been forced to tigh...

BioMed X Launches XBridge Program to Support U.S. Reacs...

As research institutions throughout the United States grapple with increasing in...

Roche Reports Promising Early Data on Alzheimer’s Drug ...

Roche has disclosed preliminary findings regarding its investigational Alzheimer...

FDA Gives Reproxalap the Red Light For Dry Eye Disease

The US Food and Drug Administration has sent a second detailed reaction letter t...

Immunovant will not pursue approval for the autoimmune ...

The latest Phase 3 trial results for Immunovant’s batoclimab drug showed achieve...

Opko & Entera Enter Partnership to Develop Obesity Pill

Opko Health and Entera Bio have formally announced their collaboration as the bi...

Taiho spends $400 million with a Swiss partner to “turb...

Taiho Pharmaceutical has paid Otsuka $400 million in upfront purchase of the Ara...

Sarepta’s Elevidys Under Scrutiny Following Fatal Liver...

A young patient diagnosed with Duchenne muscular dystrophy has passed away follo...

GSK Provides Insight Into Potential HIV Treatment Data

GSK’s ViiV Healthcare has disclosed clinical data about three prospective long-a...

Hologen AI Commits Up to $430 Million to Advance MeiraG...

Hologen AI has pledged up to $430 million through a strategic partnership to sup...

Mallinckrodt & Endo Engage in $6.7B Merger

After almost a decade of contending with bankruptcy filings and opioid settlemen...